Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NITESGON for Accelerated Long-term Forgetting in aMCI
NCT05289804Phase 2Completed
- Sponsor
- Trinity College Dublin
- Start
- Sep 2022
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD), sponsored by Trinity College Dublin. Primary endpoint: Word association task performance immediately after stimulation at 0 days. Started Sep 2022; status: completed.
02
Conditions
amnestic mild cognitive impairment (MCI)Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05289804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289804.